Organogenesis Holdings Inc.
Ticker
ORGO
ISIN
-
Price
USD 2.74
Change Today
-0.11 / -3.86 %
Price 1 year ago
3.18 / -13.836 %
Market Capitalization
271,534,304.00
52 Week Low
1.97
52 Week High
4.49
200 Day Moving Average
2.97
50-day Moving Average
2.75
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Novachor, a chorion membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering amnion and chorion membranes for spongy/intermediate layer intact; and PuraPly, a antimicrobial barrier that enables conformability and fluid drainage. Its products also include FortiShield, a biosynthetic wound matrix for use as a temporary wound covering; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly AM, PuraPly XT, and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales representives and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Country
United States
Exchange
NCM
Earnings Per Share
0.12
P/E Ratio
17.25
Debt/Equity Ratio
47.523
Beta
1.428474
Ebitda
39,500,000.00
Ebitda Margins
0.09
Enterprise to Ebitda
7.11
Enterprise Value
280,881,344.00
Target Price
-
Estimated Price
-
Book Value
2.03
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
Company | Name | Correlation |
---|---|---|
600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | -0.61 |
300039.SZ | SHANGHAI KAIBAO PH | -0.59 |
300199.SZ | HYBIO PHARMACEUTIC | -0.49 |
600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | -0.46 |
600277.SS | ELION CLEAN ENERGY CO LTD | -0.43 |
HLN.L | HALEON PLC | -0.40 |
300534.SZ | GANSU LONGSHENRONG | -0.33 |
SIDO.JK | Industri Jamu dan Farmasi Sido | -0.32 |
300026.SZ | TIANJIN CHASE SUN | -0.28 |
600380.SS | JOINCARE PHARMACEUTICAL GROUP I | -0.25 |
300158.SZ | SHANXI ZHENDONG PH | -0.24 |
600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | -0.22 |
300239.SZ | BAOTOU DONGBAO BIO | -0.14 |
0570.HK | TRAD CHI MED | -0.13 |
0460.HK | SIHUAN PHARM | -0.03 |
300110.SZ | HUAREN PHARMACEUTI | -0.00 |
300194.SZ | FUAN PHARMACEUTICA | 0.01 |
600518.SS | KANGMEI PHARMACEUTICAL CO LTD | 0.09 |
TEVA | Teva Pharmaceutical Industries | 0.10 |
600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | 0.22 |
600216.SS | ZHEJIANG MEDICINE | 0.24 |
300142.SZ | WALVAX BIOTECHNOLO | 0.24 |
002001.SZ | ZHEJIANG NHU CO | 0.39 |
600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | 0.40 |
600781.SS | FUREN GROUP PHARMACEUTICAL CO L | 0.45 |
SFLM | SFLMAVEN CORP | 0.56 |
TLRY | Tilray Brands, Inc. - Class 2 | 0.64 |
MCOA | MARIJUANA COMPANY OF AMERICA IN | 0.73 |
Similar companies
Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
---|---|---|---|---|---|---|---|---|---|
MCOA | MARIJUANA COMPANY OF AMERICA IN | Los Angeles | United States | USD | PNK | 1.15 | -1.91 | 7 | https://www.marijuanacompanyofamerica.com |
600277.SS | ELION CLEAN ENERGY CO LTD | Beijing | China | CNY | SHH | 0.81 | 14.08 | 3926 | https://www.elion.cn |
300026.SZ | TIANJIN CHASE SUN | Tianjin | China | CNY | SHZ | -0.10 | 16.16 | https://www.chasesun.cn | |
ENDP | Endo International plc | Dublin | Ireland | USD | NMS | 1.12 | 9.59 | 3103 | https://www.endo.com |
300110.SZ | HUAREN PHARMACEUTI | Qingdao | China | CNY | SHZ | 0.86 | 22.14 | 2242 | https://www.qdhuaren.com |
600518.SS | KANGMEI PHARMACEUTICAL CO LTD | Puning | China | CNY | SHH | 0.26 | -11.18 | 6410 | https://www.kangmei.com.cn |
600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | Beijing | China | CNY | SHH | -0.16 | 12.21 | 11029 | https://www.dcpc.com |
600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | Wuhan | China | CNY | SHH | 0.87 | 13.32 | 15746 | https://www.humanwell.com.cn |
SIDO.JK | Industri Jamu dan Farmasi Sido | Semarang | Indonesia | IDR | JKT | 0.14 | 15.04 | 3081 | https://www.sidomuncul.co.id |
600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | Shanghai | China | CNY | SHH | 0.65 | 30.59 | 36279 | https://www.fosunpharma.com |
HLN.L | HALEON PLC | Weybridge | United Kingdom | GBp | LSE | 16.31 | 22000 | https://www.haleon.com | |
002001.SZ | ZHEJIANG NHU CO | Xinchang | China | CNY | SHZ | 0.31 | 10.45 | 10805 | https://www.cnhu.com |
0460.HK | SIHUAN PHARM | Wan Chai | Hong Kong | HKD | HKG | 0.61 | 7.15 | 4282 | https://www.sihuanpharm.com |
TLRY | Tilray Brands, Inc. - Class 2 | Leamington | Canada | USD | NMS | -28.58 | https://www.tilray.com | ||
300199.SZ | HYBIO PHARMACEUTIC | Shenzhen | China | CNY | SHZ | 0.02 | -117.98 | 885 | https://www.hybio.com.cn |
0570.HK | TRAD CHI MED | Wan Chai | Hong Kong | HKD | HKG | 0.51 | 5.97 | 17098 | https://www.china-tcm.com.cn |
600216.SS | ZHEJIANG MEDICINE | Shaoxing | China | CNY | SHH | -0.16 | 7.75 | 5901 | https://www.zmc.top |
300194.SZ | FUAN PHARMACEUTICA | Chongqing | China | CNY | SHZ | 0.41 | 15.82 | 3004 | https://www.fapharm.com |
300039.SZ | SHANGHAI KAIBAO PH | Shanghai | China | CNY | SHZ | 0.31 | 32.28 | 1432 | https://www.xykb.com |
300142.SZ | WALVAX BIOTECHNOLO | Kunming | China | CNY | SHZ | 0.62 | 56.64 | https://www.walvax.com | |
300239.SZ | BAOTOU DONGBAO BIO | Baotou | China | CNY | SHZ | 0.26 | 43.88 | 1354 | https://www.dongbaoshengwu.com |
600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | Wuzhou | China | CNY | SHH | 0.39 | 56.88 | 3453 | https://www.wz-zhongheng.com |
300158.SZ | SHANXI ZHENDONG PH | Changzhi | China | CNY | SHZ | 0.32 | 5.06 | 4123 | https://www.zdjt.com |
600781.SS | FUREN GROUP PHARMACEUTICAL CO L | Shanghai | China | CNY | SHH | 0.27 | -5.14 | 2916 | https://www.shfuren.cn |
ZOM | Zomedica Corp. | Ann Arbor | United States | USD | ASE | 0.59 | -3.10 | 47 | https://www.zomedica.com |
300534.SZ | GANSU LONGSHENRONG | Lanzhou | China | CNY | SHZ | 0.38 | 195.38 | 302 | https://www.lsrfzy.com |
SFLM | SFLMAVEN CORP | Leamington Spa | United Kingdom | USD | PNK | 3.15 | -1.48 | 1 | https://www.dnadynamicsinc.com |
600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | Nanchang | China | CNY | SHH | 0.40 | 9.25 | 4153 | https://www.jzjt.com |
600380.SS | JOINCARE PHARMACEUTICAL GROUP I | Shenzhen | China | CNY | SHH | 0.66 | 6.07 | 13234 | https://www.joincare.com |
TEVA | Teva Pharmaceutical Industries | Tel Aviv | Israel | USD | NYQ | 1.22 | 7.45 | 34713 | https://www.tevapharm.com |
600521.SS | ZHEJIANG HUAHAI PHARMACEUTICAL | Linhai | China | CNY | SHH | 0.22 | 30.80 | 7019 | https://www.huahaipharm.com |
600664.SS | HARBIN PHARMACEUTICAL GROUP CO | Harbin | China | CNY | SHH | 9.55 | https://www.hayao.com | ||
300401.SZ | ZHEJIANG GARDEN BI | Dongyang | China | CNY | SHZ | -0.24 | 14.95 | 742 | https://www.hybiotech.com |
600568.SS | ZHONG ZHU HEALTHCARE HOLDING CO | Zhuhai | China | CNY | SHH | 0.45 | -231.66 | 1286 | https://www.zz600568.com |
CGC | Canopy Growth Corporation | Smiths Falls | Canada | USD | NMS | 2.23 | -2.61 | 3151 | https://www.canopygrowth.com |
DVLP | GOLDEN DEVELOPING SOLUTIONS INC | Fort Lauderdale | United States | USD | PNK | 1.60 | https://goldendeveloping.com | ||
SIGA | SIGA Technologies Inc. | New York | United States | USD | NGM | 0.40 | 12.13 | 39 | https://www.siga.com |
3320.HK | CHINARES PHARMA | Wan Chai | Hong Kong | HKD | HKG | 0.42 | 9.52 | 65000 | https://www.crpharm.com |
300601.SZ | SHENZHEN KANGTAI B | Shenzhen | China | CNY | SHZ | 0.31 | 17.71 | 2445 | https://www.biokangtai.com |
600267.SS | ZHEJIANG HISUN PHARMACEUTICAL C | Taizhou | China | CNY | SHH | 0.53 | 11.17 | 8280 | https://www.hisunpharm.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.